Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Unitedhealth Group Inc (NYSE: UNH) closed at $333.79 in the last session, down -2.27% from day before closing price of $341.56. In other words, the price has decreased by -$2.27 from its previous closing price. On the day, 11.08 million shares were traded. UNH stock price reached its highest trading level at $340.7 during the session, while it also had its lowest trading level at $326.6.
Ratios:
We take a closer look at UNH’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 0.84 whereas as Long-Term Debt/Eq ratio is at 0.76.
On October 14, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $406.
Robert W. Baird Downgraded its Neutral to Underperform on July 31, 2025, while the target price for the stock was maintained at $198.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 11 ’25 when Baker Charles D. sold 27 shares for $356.05 per share. The transaction valued at 9,613 led to the insider holds 0 shares of the business.
James P Schadt Trust FBO Laure bought 27 shares of UNH for $9,363 on Sep 11 ’25. On Jun 10 ’25, another insider, Conway Patrick Hugh, who serves as the Chief Executive Officer, Optum of the company, sold 589 shares for $305.00 each. As a result, the insider received 179,645 and left with 10,398 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UNH now has a Market Capitalization of 302359871488 and an Enterprise Value of 361907879936. As of this moment, Unitedhealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.42, and their Forward P/E ratio for the next fiscal year is 18.89. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.69 while its Price-to-Book (P/B) ratio in mrq is 3.16. Its current Enterprise Value per Revenue stands at 0.832 whereas that against EBITDA is 12.376.
Stock Price History:
The Beta on a monthly basis for UNH is 0.47, which has changed by -0.39763325 over the last 52 weeks, in comparison to a change of 0.18286073 over the same period for the S&P500. Over the past 52 weeks, UNH has reached a high of $630.73, while it has fallen to a 52-week low of $234.60. The 50-Day Moving Average of the stock is -2.97%, while the 200-Day Moving Average is calculated to be -13.40%.
Shares Statistics:
According to the various share statistics, UNH traded on average about 13.73M shares per day over the past 3-months and 9025130 shares per day over the past 10 days. A total of 906.00M shares are outstanding, with a floating share count of 903.68M. Insiders hold about 0.24% of the company’s shares, while institutions hold 86.40% stake in the company. Shares short for UNH as of 1760486400 were 13531383 with a Short Ratio of 0.99, compared to 1757894400 on 14238970. Therefore, it implies a Short% of Shares Outstanding of 13531383 and a Short% of Float of 1.5.
Dividends & Splits
The forward annual dividend rate for UNH is 8.62, which was 8.62 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.025237147. The stock’s 5-year Average Dividend Yield is 1.49. The current Payout Ratio is 52.75% for UNH, which recently paid a dividend on 2025-09-15 with an ex-dividend date of 2025-09-15. Stock splits for the company last occurred on 2005-05-31 when the company split stock in a 2:1 ratio.
Earnings Estimates
Current recommendations for the stock of the company come from 22.0 analysts. The consensus estimate for the next quarter is $6.63, with high estimates of $7.89 and low estimates of $5.03.
Analysts are recommending an EPS of between $16.5 and $16.0 for the fiscal current year, implying an average EPS of $16.29. EPS for the following year is $17.69, with 27.0 analysts recommending between $19.31 and $16.48.
Revenue Estimates
According to 19 analysts,. The current quarter’s revenue is expected to be $113.44B. It ranges from a high estimate of $115.57B to a low estimate of $109.15B. As of. The current estimate, Unitedhealth Group Inc’s year-ago sales were $100.81BFor the next quarter, 19 analysts are estimating revenue of $113.92B. There is a high estimate of $117.11B for the next quarter, whereas the lowest estimate is $107.8B.
A total of 23 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $449.67B, while the lowest revenue estimate was $443.5B, resulting in an average revenue estimate of $447.57B. In the same quarter a year ago, actual revenue was $400.28BBased on 23 analysts’ estimates, the company’s revenue will be $458.77B in the next fiscal year. The high estimate is $475.8B and the low estimate is $426.52B.
